An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

NCT05393895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: CSF-1
DRUG: Vehicle

Sponsor

Orasis Pharmaceuticals Ltd.